- Pharmacogenetics and Pharmacogenomics2014 | First Faculty of Medicine
- Oasis-HT: design of a pharmacogenomic dose-finding study2005 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Psychiatric pharmacogenomics2012 | First Faculty of Medicine
- A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics2016 | Second Faculty of Medicine
- Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome2018 | Faculty of Medicine in Pilsen
- Pharmacogenomics of metabolic effects of rosiglitazone2008 | First Faculty of Medicine
- Pharmacogenomics to Predict Tumor Therapy Response: A Focus on ATP-Binding Cassette Transporters and Cytochromes P4502020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Pharmacogenomics - Present, future, and perspective2012 | First Faculty of Medicine
- PPARs: molecular targets in the pharmacogenomics era2004 | First Faculty of Medicine
- PPARs: molecular targets in the pharmacogenomics era2004 | Faculty of Physical Education and Sport
- The use of 5-FU pharmacogenomics from paraffin blocks in patients with breast cancer receiving fluorouracil therapy2015 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Pharmacogenomic analysis of retinoic-acid induced dyslipidemia in congenic rat model2014 | First Faculty of Medicine
- Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics2021 | First Faculty of Medicine
- Pharmacogenomics and multiple sclerosisPublication without faculty affiliation
- Oasis-HT: design of a pharmacogenomic dose-finding study2005 | Faculty of Medicine in Pilsen
- Pharmacogenetics and pharmacogenomics of lipid-lowering drugs2017 | First Faculty of Medicine
- Institutional Profile Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicine2012 | Second Faculty of Medicine
- New pharmacogenomic model of dexamethasone-induced insulin resistance and dyslipidemiaPublication without faculty affiliation
- Some news in osteoporosis therapy2007 | Publication without faculty affiliation
- Some news in osteoporosis therapy +12007 | Faculty of Medicine in Hradec Králové
- Some news in osteoporosis therapy2007 | First Faculty of Medicine
- Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine2020 | Faculty of Medicine in Hradec Králové
- Pharmacogenomical prediction of the effect of taxifen in the treatment of hormonal-dependent post-menopausal women with breast cancer2010 | First Faculty of Medicine
- Minimum Information required for a DMET Experiment reporting2016 | Second Faculty of Medicine
- Use of Germline Genetic Variability for Prediction of Chemoresistance and Prognosis of Breast Cancer Patients2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Contribution of ABCB1 and CYP2D6 Genotypes to the Outcome of Tamoxifen Adjuvant Treatment in Premenopausal Women With Breast Cancer2015 | First Faculty of Medicine
- Pharmacogenetics and immunosuppressive drugs2014 | First Faculty of Medicine
- Sepsis Diagnostics in the Era of "Omics" Technologies2018 | First Faculty of Medicine
- Are haplotypes in a single methotrexate pathway more predictive for response in rheumatoid arthritis than in different pathways?2018 | Faculty of Medicine in Hradec Králové, Faculty of Mathematics and Physics, Faculty of Pharmacy in Hradec Králové